Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion-weighted Imaging—Comparison with Contrast-enhanced MR Imagin

Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion-weighted Imaging—Comparison with Contrast-enhanced MR Imaging and Pathologic Findings
Reiko Woodhams, Satoko Kakita, Hirofumi Hata, Keiichi Iwabuchi, Masaru Kuranami, Shiva Gautam, Hiroto Hatabu, Shinichi Kan, Carolyn Mountford
Radiology February 2010 254:357-366

Link to Journal

Diffusion-weighted MR imaging without contrast medium may provide diagnostic ability equivalent to that of contrast-enhanced MR imaging in detection of residual breast cancer after neoadjuvant chemotherapy